**Author details**

Alpana Mukhuty1 \*, Chandrani Fouzder1 , Snehasis Das2 and Dipanjan Chattopadhyay2

1 Cell Signaling Laboratory, Department of Zoology, Visva-Bharati University, Santiniketan, India

2 Molecular Endocrinology Laboratory, Department of Zoology, Visva-Bharati University, Santiniketan, India

\*Address all correspondence to: alpanamukhuty@yahoo.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**167**

2008;**4**:219

*An Insight into the Changing Scenario of Gut Microbiome during Type 2 Diabetes*

[11] Bäckhed F et al. The gut microbiota

as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America. 2004;**101**(44):15718-15723

[12] Bäckhed F et al. Host-bacterial mutualism in the human intestine. Science. 2005;**307**(5717):1915-1920

[13] Sonnenburg JL, Bäckhed F. Dietmicrobiota interactions as moderators of human metabolism. Nature.

[14] Clemente JC et al. The impact of the gut microbiota on human health: An integrative view. Cell.

[15] Barengolts E. Gut microbiota, prebiotics, probiotics and synbiotics in management of obesity and prediabetes: Review of randomized controlled trials. Endodontics: Principles and Practice.

[16] Fujimura KE et al. Role of the gut microbiota in defining human health. Expert Review of Anti Infective

[17] Murphy EF et al. Composition and energy harvesting capacity of the gut microbiota: Relationship to diet, obesity and time in mouse models. Gut.

[18] Lopez-Legarrea P et al. The influence of Mediterranean,

carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state. Asia Pacific Journal of Clinical Nutrition.

[19] Kishino S et al. Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid

Therapy. 2010;**8**(4):435-454

2010;**59**(12):1635-1642

2014;**23**(3):360-368

2016;**535**(7610):56-64

2012;**148**(6):1258-1270

2016;**22**(10):1224-1234

*DOI: http://dx.doi.org/10.5772/intechopen.90697*

[1] Robson AA. Preventing diet induced disease: Bioavailable nutrient-rich, low-energy-dense diets. Nutrition and

[2] Qin J et al. A human gut microbial

Health. 2009;**20**(2):135-166

gene catalogue established by metagenomic sequencing. Nature.

[3] Bianconi E et al. An estimation of the number of cells in the human body. Annals of Human Biology.

[4] Fukuda S, Ohno H. Gut microbiome and metabolic diseases. Seminars in Immunopathology. 2014;**36**:103-114

influencing gastrointestinal tract and microbiota immune interaction in preterm infants. Pediatric Research.

[6] Xu J et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biology. 2007;**5**:1574-1586

[7] Sekirov I et al. Gut microbiota in health and disease. Physiological Reviews. 2010;**90**(3):859-904

[9] Claus SP et al. Systemic

multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Molecular Systems Biology.

[10] Swann JR et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proceedings of the National Academy of Sciences of the United States of America.

2011;**108**(1):4523-4530

[8] Zhao L, Shen J. Whole-body systems approaches for gut microbiota-targeted, preventive healthcare. Journal of Biotechnology. 2010;**149**(3):183-190

[5] Collado MC et al. Factors

**References**

2010;**464**:59-65

2013;**40**:463-471

2015;**77**(6):726-731

*An Insight into the Changing Scenario of Gut Microbiome during Type 2 Diabetes DOI: http://dx.doi.org/10.5772/intechopen.90697*
